5 crucial new findings about Parkinson's disease you need to know today
- A groundbreaking study reveals that eye scans may detect Parkinson's disease up to seven years before clinical symptoms appear, offering a non-invasive, low-cost early screening tool that could change the course of treatment.
- Researchers have identified a new gut microbiome signature linked to Parkinson's disease, suggesting that dietary changes or probiotics could potentially slow disease progression by targeting inflammation in the gut-brain axis.
- A recent clinical trial shows that a specific type of high-intensity exercise, such as cycling or treadmill walking, can significantly improve motor function in early-stage Parkinson's patients, reducing medication reliance.
- Scientists discovered that a common diabetes drug, exenatide, may have neuroprotective effects for Parkinson's disease, with Phase 3 trials indicating slower symptom worsening over a year-long period.
- An innovative digital biomarker, using smartphone sensors to track subtle changes in finger tapping and voice patterns, is now validated for monitoring Parkinson's disease progression remotely, enabling personalized care from home.